MANAGEMENT OF ARTAVA DUSHTI W.S.R TO POLYCYSTIC OVARIAN SYNDROME WITH AROGYAVARDHINI RASA AND PATHADI CHOORNA.

Management of Artava dushti w.s.r to Polycystic ovarian syndrome with Arogyavardhini rasa and Pathadi choorna: A single arm open labelled clinical trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/030954

Enrollment

Registered

2021-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Arogyavardhini rasa and pathadi choorna: Arogyavardhini rasa 250 mg along with Pathadi choorna 5gm given orally on empty stomach both morning and evening with lukewarm water for a peri

Eligibility

Inclusion criteria

Inclusion criteria: Both married /unmarried patients in the age group of 18-40yrs. Patients with any 3 or more clinical features of PCOS like- Amenorrhea or Oligomenorrhoea Anovulation Infertility (Due to anovulation) Acne Hirsutism (Ferriman-Gallwey scale) Obesity (BMI above 25) Acanthosis nigricans Along with confirmation of any one Polycystic Ovary in USG finding.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from Pelvic/Systemic diseases like (Endometriosis, Hydrosalpinx, Fibroid uterus,). 2. Organic lesions of reproductive tract like T.B, Carcinoma and Congenital deformities. 3. Patients with history of Cardiac diseases, Chronic liver disease. 4. Age group 40yrs will be excluded. 5. Uncontrolled Hypertension (Systolic BP above 150 & Diastolic above100mmhg), Uncontrol led Diabetes mellitus (above the range of 160-200 mg/dl, FBS)

Design outcomes

Primary

Measure	Time frame
It is expected that trial drug help to improve anovulation ,oligoovulation ,hirsutism ,amenorrhea ,acne ,infertility, obesityTimepoint: 4 weeks after completion of clinical trial.	—

Secondary

Measure	Time frame
Drug may have effect on ovulation induction and conception.Timepoint: After the followup period.	—

Countries

India

Contacts

Public ContactProf Laxmipriya dei

IPGT AND RA

deilaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026